Skip to main content
. 2015 Mar 8;16(2):198–217. doi: 10.1120/jacmp.v16i2.5190

Table 7.

Mean local gamma passing rates (2%/2mm, local normalization) for the COMPASS system and mean global gamma passing rates (2%/2mm and 3%/3mm, global normalization to maximum with a low‐dose threshold at 10% of global maximum) for the COMPASS and Mobius3D systems. Results were extracted for all structures and locations of the 12 real VMAT plans

Gamma Passing Rates (%)
H&N Lung Gastric HRP IRP LRP
Local Gamma
2%/2mm
CC
83±14
66±23
72±22
84±13
87±13
82±17
CR
65±13
65±14
78±14
75±20
83±14
83±14
Global Gamma
2%/2mm
M3D
93±11
91±13
88±17
91.0±9.6
94.6±5.9
95.4±4.7
CC
95.8±6.3
98.0±4.3
98.3±4.6
96.7±3.1
99.8±0.2
99.3±0.9
CR
91±15
92±13
94.7±7.0
86±18
94.8±4.6
95.2±6.1
Global Gamma
3%/3mm
M3D
98.8±2.3
97.8±4.8
97.5±7.8
99.4±1.3
99.3±1.5
99.9±0.2
CC
98.8±2.6
99.7±0.7
99.7±1.1
99.7±0.6
100±0.0
100±0.1
CR
95.8±7.6
96.0±9.3
93±16
96.4±5.3
97.6±5.0
97.9±3.8

M3D=Mobius3D; CC=COMPASS dose calculation; CR=COMPASS dose reconstruction; H&N=head and neck; HRP=highrisk prostate; IRP=intermediaterisk prostate; LRP=lowrisk prostate.